Merck & Co., Inc.
MRK
$126.94
$1.160.92%
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -8.34% | 6.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.34% | 6.17% | |||
| Cost of Revenue | -10.30% | 5.99% | |||
| Gross Profit | -7.64% | 6.23% | |||
| SG&A Expenses | -24.04% | 2.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 44.19% | -48.93% | |||
| Operating Income | -99.79% | 220.93% | |||
| Income Before Tax | -136.41% | 205.34% | |||
| Income Tax Expenses | -194.25% | 36.58% | |||
| Earnings from Continuing Operations | -125.81% | 179.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 100.00% | -66.67% | |||
| Net Income | -125.84% | 179.41% | |||
| EBIT | -99.79% | 220.93% | |||
| EBITDA | -86.55% | 272.86% | |||
| EPS Basic | -125.88% | 179.48% | |||
| Normalized Basic EPS | -118.07% | 218.52% | |||
| EPS Diluted | -126.02% | 179.04% | |||
| Normalized Diluted EPS | -118.13% | 218.10% | |||
| Average Basic Shares Outstanding | -0.16% | -0.08% | |||
| Average Diluted Shares Outstanding | -0.51% | 0.28% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -4.86% | 2.24% | |||
